Articles
As we continue to await a meaningful treatment becoming available and/or progressing in the clinical trial setting, I have more photo results from RiverTown Therapeutics Inc. to share. This result is a continuation of a previous before and after of a 60 yr old male that has been shared on Follicle Thought from RiverTown. This…
A new therapy targeting the PRL receptor to treat male and female pattern hair loss is being developed by a Chinese biopharmaceutical compay and Bayer AG. A press release was sent out April 7, 2019 by Hope Medicine Inc. detailing a newly signed licensing agreement with Bayer AG for the development of treatments for hair…
I’ve received an update regarding the anticipated NGF-574H stem-cell derived cosmetic for hair growth which was originally developed by Medipost. According to Jay Lee, CEO of Celino Inc., Medipost has spun off its cosmetics business including the products NGF-574H and NGF-37 (for skin) into a new company called Celino Inc. Last year, it was reported…
A website for Rapunzel Biosciences, the hair growth biotech company founded by Angela Christiano, has finally surfaced online. It was several years ago when Dr. Christiano mentioned that she was forming a company called “Rapunzel” which was aimed at using stem cells to create hair follicle regeneration in the scalp. We did not hear anything…
Replicel has shared a newsletter today, March 5, 2019, addressing several facets of the company’s progress and product development. The big question for many people lately has been an update on RCH-01/Shiseido, this topic is briefly addressed in the newsletter. Replicel states that “With the clinical study of RCH-01 now successfully completed in Japan, RepliCel…
I’ve been given a few samples of the male Trinov version and I thought it would be fun to do a little giveaway. Let’s start with one bottle. The winner selection will be random but please share a few words on how Follicle Thought has helped your life or something else you feel would make…
HairClone of the UK will be winding up its crowdfunding campaign soon. Paul Kemp, CEO of HairClone, has released the 6th official HairClone newsletter today. The main theme of the newsletter is to allow people a last chance opportunity to own shares in HairClone via its crowdfunding campaign on CapitalCell. The rest of the newsletter…
On February 4, 2019 Follicum announced via press release they have completed a preclinical trial using a new cream-like topical formulation of their peptide FOL-005. In the trial, Follicum measured the effects of their topical FOL-005 against industry standard hair-growth drug minoxidil. The trial was done on mice and took about four weeks to complete.…
Please enjoy the second part of our interview series with Paul Kemp PhD, CEO of HairClone. FT: Can you give us a step-by-step of how a therapy like HairClone’s goes from the R&D phase into the clinical setting? PK: If you consider it at its very simplest there are 4 players involved in any treatment. The…
RiverTown Therapeutics has engaged in an academic research collaboration to validate an effect of RT1640 that has already been observed in humans – gray hair reversal. A collaboration has begun between RiverTown Therapeutics and The University of Alabama at Birmingham with well-known hair pigment researcher Dr. Melissa Harris. You may remember Dr. Melissa Harris as…